Drug Patent Expirations in April 2012

*Drugs may be covered by multiple patents

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
BROVANA	Sunovion	arformoterol tartrate	6,068,833	Apr 3, 2012
BROVANA	Sunovion	arformoterol tartrate	6,866,839	Apr 3, 2012
BROVANA	Sunovion	arformoterol tartrate	6,589,508	Apr 3, 2012
BROVANA	Sunovion	arformoterol tartrate	5,795,564	Apr 3, 2012
ALTACE	King Pfizer	ramipril	5,403,856	Apr 4, 2012
TRITEC	Glaxosmithkline	ranitidine bismuth citrate	5,403,830	Apr 4, 2012
ALTACE	King Pharms	ramipril	5,403,856	Apr 4, 2012
TRITEC	Glaxosmithkline	ranitidine bismuth citrate	5,407,688	Apr 4, 2012
MULTIHANCE	Bracco	gadobenate dimeglumine	4,916,246	Apr 10, 2012
MULTIHANCE MULTIPACK	Bracco	gadobenate dimeglumine	4,916,246	Apr 10, 2012
LESCOL	Novartis	fluvastatin sodium	5,354,772*PED	Apr 11, 2012
COMBIVENT RESPIMAT	Boehringer Ingelheim	albuterol sulfate; ipratropium bromide	5,405,084	Apr 11, 2012
LESCOL XL	Novartis	fluvastatin sodium	5,354,772*PED	Apr 11, 2012
TARGRETIN	Eisai Inc	bexarotene	6,320,074	Apr 22, 2012
TARGRETIN	Eisai Inc	bexarotene	7,655,699	Apr 22, 2012
TARGRETIN	Eisai Inc	bexarotene	6,043,279	Apr 22, 2012
OPTISON	Ge Healthcare	albumin human	5,573,751	Apr 25, 2012
NAVSTEL	Alcon Pharms Ltd	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	5,409,904	Apr 25, 2012
NAVSTEL	Alcon Pharms Ltd	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	5,578,578	Apr 25, 2012